Cavco Industries, Inc. (NASDAQ:CVCO) Q3 2023 Earnings Conference Call February 3, 2023 1:00 PM ET
Company Participants
Mark Fusler - Corporate Controller & IR
Bill Boor – President & CEO
Allison Aden – EVP & CFO
Paul Bigbee - Chief Accounting Officer
Conference Call Participants
Daniel Moore - CJS Securities
Danny Eggerichs - Craig-Hallum
Jay McCanless - Wedbush
Operator
Thank you for standing by and welcome to the Third Quarter Fiscal Year 2023 Cavco Industries, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder today’s conference call is being recorded.
I would now like to turn the conference to your host Mr. Mark Fusler, Corporate Controller and Investor Relations. Please go ahead.
Mark Fusler
Good day, and thank you for joining us for Cavco Industry's third quarter fiscal year 2023 earnings conference call. During this call, you'll be hearing from Bill Boor, President and Chief Executive Officer; Allison Aden, Executive Vice President and Chief Financial Officer; and Paul Bigbee, Chief Accounting Officer.
Before we begin, we'd like to remind you that the comments made during this conference call by management may contain forward-looking statements, including the statements of expectations or assumptions about Cavco's financial and operational performance, revenues, earnings per share, cash flow or use, cost savings, operational efficiencies, current or future volatility in the credit markets or future market conditions.
All forward-looking statements involve risks and uncertainties, which could affect Cavco's actual results and could cause its actual results to differ materially from those expressed in any forward-looking statements made by or on behalf of Cavco.
I encourage you to review Cavco's filings with the Securities and Exchange Commission, including without limitation, the company's most recent Forms 10-K and 10-Q which
- Read more current CVCO analysis and news
- View all earnings call transcripts